retatrutide clinical trial data Retatrutide—A Game Changer in Obesity Pharmacotherapy Eli Lilly infiltrates anti-obesity market

By consulting with our team, clients can embark on a safe and effective weight management journey that aligns with their personal goals and lifestyle

Genetic Factors That May Influence Your GLP-1 Digestive Response Your genetic makeup influences how strongly your body responds to GLP-1 signaling and how severe gastrointestinal side effects may be

Myth: Heartburn means tirzepatide is damaging your stomach

In recent years, GIP/GLP-1 receptor dual agonists and GIP/GLP-1/glucagon receptor triple agonists, which co-stimulate multiple hormone receptors including GIPR, continue to be reported to exert remarkable anti-obesity and hypoglycaemic effects when compared to agonists of the GLP-1R alone, and are now being applied in clinical practice

By contrast, GLP-1 receptor agonists delay gastric emptying, but DPP-4 inhibitors do not [6]